Cisatracurium besylate
- Product NDC
- 66794-246
- 11-digit product format
- 667940246
- Labeler code
- 66794
- Product ID
- 66794-246_e2719e22-2218-2d0c-e053-2a95a90a5b94
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cisatracurium besylate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- PIRAMAL CRITICAL CARE INC
- Application
- ANDA215516
- Marketing category
- ANDA
- Marketing start
- 2022-08-01
- Marketing end
- 0000-00-00
- Substance
- CISATRACURIUM BESYLATE
- Active strength
- 200 mg/20mL
- Pharmacologic classes
- Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 66794-246-02 | 66794024602 | 20 mL in 1 VIAL (66794-246-02) | 20 ml | 2022-08-01 | 0000-00-00 | No | No | Current |